Trials / Recruiting
RecruitingNCT04699305
Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- RedDress Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ActiGraft | Whole blood clot (WBC) gel |
Timeline
- Start date
- 2019-02-14
- Primary completion
- 2026-07-01
- Completion
- 2027-01-31
- First posted
- 2021-01-07
- Last updated
- 2025-07-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04699305. Inclusion in this directory is not an endorsement.